TCGX is a registered investment advisor based in Palo Alto, California. TCGX invests in both private and public opportunities, focusing on innovative pre-IPO and public drug discovery companies. We invest in visionary entrepreneurs leveraging recent scientific breakthroughs to develop transformative medicines.
Company Details
- Employees
- 15
- Address
- A Critical Public Health Need. Vicebio Has A Unique Capability To Advance Vaccine Products That Simultaneously Provide Robust Immune Responses Against Multiple Respiratory Pathogens. We Look Forward To Working Closely With The Team To Bring These Important Vaccines To Market."
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.tcgcrossover.com
Tcgx Questions
Tcgx's website is http://www.tcgcrossover.com
Tcgx's LinkedIn profile is https://www.linkedin.com/company/tcg-crossover
Tcgx has
15 employees.
View email and phone details for 15
employees at Tcgx.
Tcgx's industry is
Biotechnology Research
Tcgx's top competitors are
Spruce Street Capital Lp,
Aquilo Capital Management,
Avoro Capital,
Vicebio,
Foresite Capital,
Aisling Capital,
Dawn Biopharma,
Venbio,
Venrock,
Medicxi.
Tcgx's categories are Biotechnology Research
